文献速递肾小球疾病急性肾损伤慢性肾脏病

儿童ANCA相关性血管炎肾脏病理评分结局与验证

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.
PubMed 文献 · Kidney Int Rep · 2026-04-21

儿童起病时肾病范围蛋白尿、贫血及皮肤胃肠道受累更常见,病理活动性更高,但肾脏结局与成人相当;Berden分类、ARRS和AKRiS对儿童预后有良好预测准确性。

要点

  • 儿童AAV起病时肾病范围蛋白尿和严重贫血较成人更常见。
  • 儿童肾活检病理活动性更高,但肾脏结局与成人相当。
  • Berden分类、ARRS和AKRiS可用于儿童AAV肾脏预后预测。

核心结论

  • 儿童AAV起病时肾脏病理活动性更高、肾病范围蛋白尿和严重贫血更常见,但肾脏结局与成人相当。
  • Berden分类、ARRS和AKRiS在儿童AAV中显示良好的肾脏预后预测准确性。

主要发现

  • 与成人(中位年龄66岁,52%男性)相比,儿童肾病范围蛋白尿更常见(42% vs. 18%,P < 0.001),血红蛋白更低(8.7 vs. 9.7 g/dl,P < 0.001)。
  • 儿童皮肤受累(24% vs. 9%,P = 0.001)和胃肠道受累(18% vs. 3%,P < 0.001)更常见。
  • 儿童病理新月体形成更多(P < 0.001),局灶型更少(P < 0.001),IF/TA 0比例更高(41% vs. 19%,P = 0.001),间质炎症ti1-2-3更多(66% vs. 47%,P = 0.025)。
  • 儿童诱导治疗更常用利妥昔单抗(65% vs. 43%,P = 0.001)和血浆置换(31% vs. 15%,P = 0.004)。
  • 重复活检显示活动性降低并向纤维化进展。

临床怎么用

  • 儿童AAV起病时应关注肾病范围蛋白尿和严重贫血,肾活检病理活动性常较高。
  • Berden分类、ARRS和AKRiS可用于儿童AAV肾脏预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is rare in children, kidney involvement is both common and potentially severe. Data on the clinico-pathological presentation and progression of kidney involvement in pediatric AAV are limited. METHODS: This multicentric, retrospective, observational study aims to characterize kidney involvement in pediatric AAV, through a centralized pathology review of kidney biopsies and comparisons with an adult AAV cohort. RESULTS: Eighty-one pediatric patients (median age 12.7 years, 23% male) were included over 20 years. Compared with adults (median age 66 years, 52% male), children presented with more frequent nephrotic-range proteinuria (42% vs. 18%, P < 0.001), lower hemoglobin levels (8.7 vs. 9.7 g/dl, P < 0.001), and more common cutaneous (24% vs. 9%, P = 0.001) and gastrointestinal involvement (18% vs. 3%, P < 0.001); histologically, more crescentic (P < 0.001) and fewer focal forms (P < 0.001), less interstitial fibrosis and tubular atrophy (IF/TA 0: 41% vs. 19%, P = 0.001) and more interstitial inflammation (ti1-2-3 per Banff classification: 66% vs. 47%, P = 0.025). For induction treatment children had a more frequent use of rituximab (65% vs. 43%, P = 0.001) and plasma exchange (31% vs. 15%, P = 0.004). Kidney outcomes were comparable to adults. The Berden classification, ANCA Renal Risk Score (ARRS), and ANCA Kidney Risk Score (AKRiS) showed good predictive accuracy for pediatric patients. Repeat biopsies demonstrated reduced activity and progression towards fibrosis. CONCLUSION: Pediatric patients present a more active kidney histology than adults, a more frequent nephrotic-range proteinuria and more severe anemia at presentation. Despite this, outcomes are comparable to adults. Berden, ARRS, and AKRiS can be used for predicting kidney prognosis in the pediatric population.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Pucci C, Ursule-Dufait C, Gnemmi V, et al. Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis. Kidney Int Rep. 2026. PMID: 42254853. doi:10.1016/j.ekir.2026.106565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。